Co-Founder And Managing Partner
CurrentSeed stage investing in the 'picks and shovels' of life science R&D.
Jan 2023 - Present
AeroLeads people directory · profile
Will Alaynick Email & Phone Number
Scientist, Founder, Operator, Investor
at
Phase Two Ventures
1 work email found
@nanocellect.com
2 phones found area 619 and 877
LinkedIn matched
✓ Verified May 2026
4 data sources
Profile completeness 100%
Current company
Role
Scientist, Founder, Operator, Investor
Location
San Diego, California, United States
Who is Will Alaynick? Overview
A concise factual answer block for searchers comparing this professional profile.
Quick answer
Will Alaynick is listed as Scientist, Founder, Operator, Investor at Phase Two Ventures, based in San Diego, California, United States. AeroLeads shows a work email signal at nanocellect.com, phone signal with area code 619, 877, and a matched LinkedIn profile for Will Alaynick.
Will Alaynick previously worked as Co-Founder and Managing Partner at Phase Two Ventures and Co-Founder, Board of Directors at Defined Bioscience. Will Alaynick holds Postdoctoral Fellowship, Developmental Neurobiology Of The Spinal Cord from The Salk Institute For Biological Studies.
Company email context
Email format at Phase Two Ventures
This section adds company-level context without repeating Will Alaynick's masked contact details.
{first}@nanocellect.com
86% confidence
AeroLeads found 1 current-domain work email signal for Will Alaynick. Compare company email patterns before reaching out.
Profile bio
About Will Alaynick
Investing in life science tools based on my experience founding and operating life science tools, reagent, medical device, and diagnostics companies. I've grown these companies from academic concept to global sales backed by capital from top-tier venture, private equity, and strategic investors--as well as NIH SBIR awards. I've led fundraising, domestic and international sales teams, and product development. Performed molecular/cellular neuroscience and molecular endocrinology research in 4 HHMI labs, and 4 National Academy mentors. 32 peer-reviewed papers and 18 patents across 5 families.
Listed skills include Molecular Biology, Biochemistry, Neuroscience, Cell, and 37 others.
Current workplace
Will Alaynick's current company
Company context helps verify the profile and gives searchers a useful next step.
15 roles
Will Alaynick work experience
A career timeline built from the work history available for this profile.
Co-Founder, Board Of Directors
Current- Rationally designed, chemically defined, animal product free, cell culture media and growth factors for stem cells and cultured meat.
- NIH, NSF and CIRM award winning R&DAlong with 4 others, I co-founded Defined Bioscience in late 2019. Helped raise financing from NIH SBIRs, industry trade groups, and venture capital. Established sales & marketing.
Dec 2019 - Present
Co-Founder, Advisor
Current
Jan 2024 - Present
Co-Founder, Executive
Along with 4 others, I co-founded NanoCellect to commercialize technology from Professor Yuhwa Lo's lab at UCSD. I held leadership and operational roles in: US and International Sales, Product Development, Fundraising, Corporate Strategy, Business Development, M&A, and Intellectual Property. 18 US and international patents.
Nov 2009 - Dec 2023
Co-Founder
Current- Arima Genomics is advancing the life sciences through the power of 3D genomes. We develop innovative solutions that drive discovery in genomics and improve human health.
- Joint Venture, Aventa Genomics, with Aventa FusionPlus that detects gene fusions, translocations, and other rearrangements across 361 genes from FFPE samples.
- NIH award winning R&D
- > 300 customer publications
Nov 2017 - Present
Coo, Director
Along with 4 others, I co-founded Arima Genomics as an academic spinout from Bing Ren's lab at UCSD with technology from Job Decker's lab at UMass. As Director and COO, I helped carry out research contracts for Big Pharma, raise funding from NIH SBIRs, and develop RUO kits for phasing and novel genome sequencing. I left my employment in late 2017 when.
Jan 2015 - Nov 2017
Co-Founder, Managing Partner
Current
Scholarnexus, Llc
- ScholarNexus accelerates technologies from concept through revenue. We have helped our companies raise nearly $40M in non-dilutive funding and nearly $100M in strategic and venture investment.
- http://scholarnexus.com/
Jul 2007 - Present
Director, Product Development
- Joined founding team of UCLA spinout, NeuroEnabling Technologies, developing external and implantable spinal cord stimulators to improve bladder and autonomic function in patients with spinal cord injury and paralysis..
- Merged with GTX Medical in 2019
- IPO 2021 as ONWD
Feb 2012 - Feb 2014
Senior Research Associate, Samuel Pfaff Lab
Cellular and molecular biology and electrophysiology of the developing spinal cord with Dr. Samuel Pfaff (AAAS) in the Howard Hughes Medical Institute at The Salk. I studied how Central Pattern Generator circuitry of the lumbar spinal cord develops as a model of neural circuitry resulting in 8 publications including Cell, Science, and Neuron.
Dec 2006 - Dec 2012
Graduate Student, Ronald Evans Lab
Doctoral research in nuclear hormone receptor biology with Ronald M. Evans, PhD (NAS, NAM, AAAS) at The Salk and HHMI resulting in 10 publications.
Jan 2002 - Nov 2006
Graduate Student, Larry Goldstein Lab
Rotation Student in Larry Goldstein, PhD (NAS, AAAS) lab at UCSD studying the neuroscience of tyrosine hydroxylase / catecholamine-deficient drosophila.
Jun 2001 - Dec 2001
Research Technician, Richard Palmiter Lab
Characterized transgenic mouse models of neurologic disease in the laboratory of Richard Palmiter, PhD (NAS, AAAS) in the Department of Biochemistry and HHMI at The University of Washington, Seattle. This resulted in 2 publications.
Jun 1998 - Jun 2001
Research Associate
The Christopher & Dana Reeve Foundation is dedicated to curing spinal cord injury by funding innovative research, and improving the quality of life for people living with paralysis through grants, information and advocacy.
Oct 2007 - Sep 2012
Advisory Board
- SweetSpot is a health data company focused on improving the use of data in the treatment of diabetes. SweetSpot specializes in turning raw output from patient devices into reports that are powerful for researchers.
- Helped pivot from a consumer product to a clinician and EMR focus.
- Acquired by Dexcom as a wholly-owned subsidiary for $8.5M in 2012.
Jan 2009 - Mar 2012
Emergency Medicine Student
University Of Washington Medical Center
Gained clinical experience by shadowing the Director of Emergency Medicine, Mickey Eisenberg, MD, PhD, MPH (NAM) and his colleagues during undergraduate years.
Feb 1996 - Jun 1998
4 education records
Will Alaynick education
Postdoctoral Fellowship, Developmental Neurobiology Of The Spinal Cord
The Salk Institute For Biological Studies
Global Business Series: Destination China
University Of California, San Diego - Rady School Of Management
Phd, Biomedical Sciences At Salk Institute
Uc San Diego School Of Medicine
Ba, History Of Science And Pre-Medical
University Of Washington
FAQ
Frequently asked questions about Will Alaynick
Quick answers generated from the profile data available on this page.
What company does Will Alaynick work for?
Will Alaynick works for Phase Two Ventures.
What is Will Alaynick's role at Phase Two Ventures?
Will Alaynick is listed as Scientist, Founder, Operator, Investor at Phase Two Ventures.
What is Will Alaynick's email address?
AeroLeads has found 1 work email signal at @nanocellect.com for Will Alaynick at Phase Two Ventures.
What is Will Alaynick's phone number?
AeroLeads has found 2 phone signal(s) with area code 619, 877 for Will Alaynick at Phase Two Ventures.
Where is Will Alaynick based?
Will Alaynick is based in San Diego, California, United States while working with Phase Two Ventures.
What companies has Will Alaynick worked for?
Will Alaynick has worked for Phase Two Ventures, Defined Bioscience, Nanocellect Biomedical, Inc., Arima Genomics, Inc., and Scholarnexus, Llc.
How can I contact Will Alaynick?
You can use AeroLeads to view verified contact signals for Will Alaynick at Phase Two Ventures, including work email, phone, and LinkedIn data when available.
What schools did Will Alaynick attend?
Will Alaynick holds Postdoctoral Fellowship, Developmental Neurobiology Of The Spinal Cord from The Salk Institute For Biological Studies.
What skills is Will Alaynick known for?
Will Alaynick is listed with skills including Molecular Biology, Biochemistry, Neuroscience, Cell, Lifesciences, Life Sciences, Genomics, and Cell Culture.
Find 750M verified contacts
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial